854766-38-4Relevant articles and documents
5-Lipoxygenase modulators
-
Page/Page column 13, (2008/06/13)
The present invention provides the use of Liver X Receptor (LXR) modulators that have been identified to downregulate 5-lipoxygenase gene expression in order to treat various diseases and disorders that involve the function of the 5-LO protein in intracel
Quinolines useful in treating cardiovascular disease
-
Page/Page column 41, (2008/06/13)
This invention provides compounds of formula I that are useful in the treatment or inhibition of LXR mediated diseases.